Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies

CONCLUSION: COVID-19 vaccines significantly reduce the risk of severe outcomes in cancer patients, though their efficacy against breakthrough infections is less evident.PMID:38554591 | DOI:10.1016/j.jiph.2024.03.015
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research